Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Upslanted palpebral fissure, Short palpebral fissure, Flat face, and Thin upper lip vermilion and others; and common findings: Epicanthus, Square face, Strabismus, and Absent earlobe and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Intellectual disability, Delayed speech and language development, Depressed nasal bridge |
EP300 encodes EP300 lysine acetyltransferase (2,414 aa). Functions as a histone acetyltransferase and regulates transcription via chromatin remodeling. Acetylates all four core histones in nucleosomes. Highest expression in Testis (49.5 TPM) and Brain Cerebellum (47.8 TPM).
Menke-Hennekam syndrome 2 is associated with mutations in the EP300 gene on chromosome 22.
The EP300 protein participates in p-AcK-NFE2L2:CREBBP, EP300, p-T,4S-IRF3:p-T,4S-IRF3:CREBBP, EP300, and GSTA1 gene:p-AcK-NFE2L2:MAFK:CREBBP, EP300 pathways.
EP300 is classified as a druggable target (Clinically Actionable, Druggable Genome, Enzyme, and Transcription Factor Complex categories) with score 8.7.
Genetic testing for EP300 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 10 always present features, 18 common features.
No clinical trials have been registered for Menke-Hennekam syndrome 2.
4 publications have been identified in PubMed for Menke-Hennekam syndrome 2. Research spans Review / Meta-Analysis (25%), Case Report / Case Series (25%), and Basic Science / Preclinical (25%).
Pavinato L (2025). [PMID: 39603792](https://pubmed.ncbi.nlm.nih.gov/39603792/). *Clin Genet*. [Basic Science / Preclinical]
Barua S (2025). [PMID: 40421630](https://pubmed.ncbi.nlm.nih.gov/40421630/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Kawai T (2025). [PMID: 41309537](https://pubmed.ncbi.nlm.nih.gov/41309537/). *Hum Genome Var*. [Epidemiology / Natural History]
Wang Y (2025). [PMID: 40672389](https://pubmed.ncbi.nlm.nih.gov/40672389/). *Front Genet*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:07 PM UTC
Online Mendelian Inheritance in Man
Common questions about Menke-Hennekam syndrome 2
Head and neck |
3 |
Square face, Flat face, Thin upper lip vermilion |
Arms and legs | 2 | Cutaneous syndactyly of toes, Overlapping toe |
Eyes | 1 | Strabismus |
Ears | 1 | Hearing loss (hearing impairment) |
Digestive system | 1 | Chronic constipation |
Bones and joints | 1 | Joint hypermobility |
Lungs and breathing | 1 | Recurrent upper respiratory tract infections |
Blood and immune system | 1 | Recurrent upper respiratory tract infections |